Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

2-(benzo(d)thiazol-2-yl)-4,5,6,7-tetrahydro-2H-indazol-3-oic acid MeSH Supplementary Concept Data 2025


MeSH Supplementary
2-(benzo(d)thiazol-2-yl)-4,5,6,7-tetrahydro-2H-indazol-3-oic acid
Unique ID
C000607543
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000607543
Entry Term(s)
2-(benzo(d)thiazol-2-yl)-4,5,6,7-tetrahydro-3-hydroxy-2H-indazole
BD926 compound
sodium 2-(benzo(d)thiazol-2-yl)-4,5,6,7-tetrahydro-2H-indazol-3-olate
Registry Numbers
0
Heading Mapped to
*Benzimidazoles
*Indazoles
Frequency
1
Note
has immunosuppressive activity; structure in first source
Source
Eur J Pharmacol. 2015 Aug 15;761:36-43.
Date of Entry
2016/05/15
Revision Date
2016/05/15
2-(benzo(d)thiazol-2-yl)-4,5,6,7-tetrahydro-2H-indazol-3-oic acid Preferred
sodium 2-(benzo(d)thiazol-2-yl)-4,5,6,7-tetrahydro-2H-indazol-3-olate Narrower
page delivered in 0.005s